APLT - Applied Therapeutics GAAP EPS of -$0.18 beats by $0.25
2023-05-11 09:02:34 ET
- Applied Therapeutics press release ( NASDAQ: APLT ): Q1 GAAP EPS of -$0.18 beats by $0.25 .
- Cash and cash equivalents and short-term investments totaled $22.9 million as of March 31, 2023, compared with $30.6 million at December 31, 2022.
For further details see:
Applied Therapeutics GAAP EPS of -$0.18 beats by $0.25